- Preview Available
- Scholarly Journal
Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon response via MYC/CDK2/DNMT1 pathway
Nature Communications; London Vol. 16, Iss. 1, (2025): 5154.
DOI:10.1038/s41467-025-60293-4
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.